Page last updated: 2024-12-08

mk 761

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

MK 761: RN given refers to parent cpd(S)-isomer; MK-761 refers to mono-HCl; structure in sixth source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID181285
CHEMBL ID349529
SCHEMBL ID4309499
MeSH IDM0075923

Synonyms (4)

Synonym
OPREA1_627194
mk 761
CHEMBL349529
SCHEMBL4309499
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID57652Tested for increase in iliac blood flow was measured in anesthetized dogs after timolol administered intravenous at dose 800 mg/kg1980Journal of medicinal chemistry, Jan, Volume: 23, Issue:1
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
AID57651Tested for increase in iliac blood flow was measured in anesthetized dogs after timolol administered intravenous at dose 2000 mg/kg1980Journal of medicinal chemistry, Jan, Volume: 23, Issue:1
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
AID57657Tested for increase in iliac blood flow was measured in anesthetized dogs before timolol administered intra arterially at dose 64 mg/kg; ND = no data1980Journal of medicinal chemistry, Jan, Volume: 23, Issue:1
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
AID57649Tested for increase in iliac blood flow was measured in anesthetized dogs after timolol administered intra arterially at dose 800 mg/kg1980Journal of medicinal chemistry, Jan, Volume: 23, Issue:1
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
AID187013Tested for maximum fall in mean arterial pressure in Spontaneously hypertensive rats after peroral administration by using 1% methyl cellulose as vehicle at 1.25 mg/kg1980Journal of medicinal chemistry, Jan, Volume: 23, Issue:1
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
AID1137407Toxicity in rabbit assessed as teratogenicity measured after high drug dose administration1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agents.
AID57654Tested for increase in iliac blood flow was measured in anesthetized dogs before timolol administered intra arterially at dose 250 mg/kg; ND = no data1980Journal of medicinal chemistry, Jan, Volume: 23, Issue:1
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
AID187010Tested for maximum fall in mean arterial pressure in Spontaneously hypertensive rats after peroral administration by using 1% methyl cellulose as vehicle at 0.312 mg/kg1980Journal of medicinal chemistry, Jan, Volume: 23, Issue:1
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
AID59473Beta adrenergic blockade activity was measured in anesthetized dogs by blockade of isoproterenol induced tachycardia after iv administration1980Journal of medicinal chemistry, Jan, Volume: 23, Issue:1
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
AID57653Tested for increase in iliac blood flow was measured in anesthetized dogs before timolol administered intra arterially at dose 1600 mg/kg1980Journal of medicinal chemistry, Jan, Volume: 23, Issue:1
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
AID1137404Antihypertensive activity in po dosed spontaneously hypertensive Wistar-Okamoto rat assessed as maximal fall in mean arterial pressure1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agents.
AID186876Tested for maximum fall in mean arterial pressure in Spontaneously hypertensive rats after peroral administration by using 1% methyl cellulose as vehicle at 0.078 mg/kg1980Journal of medicinal chemistry, Jan, Volume: 23, Issue:1
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
AID59472Beta adrenergic blockade activity was measured in anesthetized dogs by blockade of isoproterenol induced hypotension after iv administration1980Journal of medicinal chemistry, Jan, Volume: 23, Issue:1
Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]